Discover why Sea Limited (SE) thrives amid global headwinds, driven by robust consumer trends, diversified offerings, and ...

At a market cap of 4.7B EUR and EV/EBITDA of 4.8, Arkema is attractively priced, even with a potential 15% EBITDA reduction.

Mastercard is definitely a wonderful business, both when assessed qualitatively and quantitatively. The future risks for the ...

When markets move, we can learn a lot from the outperformers. But we can also learn a lot from the underperformers - and ...

Adriatic Metals PLC upgraded to Buy due to Vareš project ramp-up, expected commercial production in Q1 2025, and favorable ...

KREF's Series A is attractively priced for a company with a credit rating of B+. Though current yields of near 9% exist, ...

Rocket Lab's heavy reliance on government contracts makes it especially vulnerable to cost-cutting in this sector. Check out ...

VitalHub, a healthcare software provider, has seen an 18% drop since January 2025 despite a 30% revenue growth during FY2024.

Shares International Select Dividend ETF (IDV) faces a hold rating due to high fees, weaker fundamentals, and lower dividend ...

OPTZ, a unique all-cap ETF with GARP features. Low 14.77x P/E and high-growth potential, but higher risk. See more on OPTZ ...

Rising medical costs impacted UnitedHealth's earnings and market cap. Read about UNH's long-term growth potential despite its ...

Uber (UBER) outpaces the S&P 500 in 2025 with 21% YTD growth. See more on UBER's strong Q4 results, growth initiatives, and ...